跳至主要内容
临床试验/CTRI/2021/06/034467
CTRI/2021/06/034467尚未招募未知

Effect Of Intraoperative Single Dose Ketorolac On Release Of Vegf And Tgf-Î? In Patients Undergoing Breast Cancer Resection â?? A Prospective Randomized Trial.

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. > 18 years < 75 years, female patients with histologically proven breast cancer.
  • 2.Posted for MRM, lumpectomy or BCS.
  • 3.ASA I to III

排除标准

  • 1.Not consenting for study.
  • 2.Bilateral breast surgery
  • 3.Allergic to use of NSAIDâ??s
  • 4. Weight <50 or > 100 kg.
  • 5.Renal dysfunction, history of upper GI bleed, bleeding diathesis.
  • 6.History of invasive cancer in last 5 years.
  • 7.Chronic use of NSAIDâ??s for other painful conditions
  • 8.Patients received neoadjuvant chemotherapy (NACT) before surgery

研究者

相似试验

Effect of Ketorolac of VEGF and TGF-B release in... | 临床试验